Skip to main content
padlock icon - secure page this page is secure
Current Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular drug targets involved in cancer, e.g. disease specific proteins, receptors, enzymes, genes.
Each issue of the journal contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in cancer.
As the discovery, identification, characterization and validation of novel human drug targets for anti-cancer drug discovery continues to grow; this journal has become essential reading for all pharmaceutical scientists involved in drug discovery and development.

Publisher: Bentham Science Publishers

Volume 13, Number 8, October 2013

Articles

Protein Phosphatase 2A as a Potential Target for Treatment of Adult T Cell Leukemia
pp. 829-842(14)
Authors: Mori, Naoki; Ishikawa, Chie; Uchihara, Jun-Nosuke; Yasumoto, Takeshi

Favourites:
ADD

Signal Transduction in Human Cutaneous Melanoma and Target Drugs
pp. 843-866(24)
Authors: B. Uzdensky, Anatoly; V. Demyanenko, Svetlana; Y. Bibov, Mikhail

Favourites:
ADD

β-Catenin Knockdown in Liver Tumor Cells by a Cell Permeable Gamma Guanidine-based Peptide Nucleic Acid
pp. 867-878(12)
Authors: Delgado, Evan; Bahal, Raman; Yang, Jing; M. Lee, Jung; H Ly, Danith; P. S. Monga, Satdarshan

Favourites:
ADD

Ipilimumab and Vemurafenib: Two Different Routes for Targeting Melanoma
pp. 879-894(16)
Authors: Burgeiro, Ana; Mollinedo, Faustino; J. Oliveira, Paulo

Favourites:
ADD

Significance of Prion and Prion-Like Proteins in Cancer Development, Progression and Multi-Drug Resistance
pp. 895-904(10)
Authors: Hinton, Caroline; Antony, Helma; M. Hashimi, Saeed; Munn, Alan; Q. Wei, Ming

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more